Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × Rectal Neoplasms × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

OTHER 1659 NIH 194 INDUSTRY 158 NETWORK 77 OTHER_GOV 64 UNKNOWN 15 FED 5 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 5 Carcinoma, Hepatocellular 3 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Carcinoma in Situ 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Gastroesophageal Reflux 1 Fibrosis 1 Esophageal Neoplasms 1 Colonic Polyps 1 Colonic Neoplasms 1 Adenocarcinoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01613469 2018-08-16

Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer

Marks, John, M.D.

Phase 2 Terminated

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡